메뉴 건너뛰기




Volumn 31, Issue 2, 2017, Pages 172-179

Liquid Biopsies, What We Do Not Know (Yet)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPLAST DNA; DNA;

EID: 85012886951     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2017.01.002     Document Type: Review
Times cited : (391)

References (77)
  • 1
    • 84964700391 scopus 로고    scopus 로고
    • Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy
    • Alix-Panabières, C., Pantel, K., Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov. 6 (2016), 479–491.
    • (2016) Cancer Discov. , vol.6 , pp. 479-491
    • Alix-Panabières, C.1    Pantel, K.2
  • 4
    • 84896091512 scopus 로고    scopus 로고
    • ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics
    • Arteaga, C.L., Engelman, J.A., ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25 (2014), 282–303.
    • (2014) Cancer Cell , vol.25 , pp. 282-303
    • Arteaga, C.L.1    Engelman, J.A.2
  • 5
    • 84933510527 scopus 로고    scopus 로고
    • Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer
    • Azad, A.A., Volik, S.V., Wyatt, A.W., Haegert, A., Le Bihan, S., Bell, R.H., Anderson, S.A., McConeghy, B., Shukin, R., Bazov, J., et al. Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer. Clin. Cancer Res. 21 (2015), 2315–2324.
    • (2015) Clin. Cancer Res. , vol.21 , pp. 2315-2324
    • Azad, A.A.1    Volik, S.V.2    Wyatt, A.W.3    Haegert, A.4    Le Bihan, S.5    Bell, R.H.6    Anderson, S.A.7    McConeghy, B.8    Shukin, R.9    Bazov, J.10
  • 14
    • 84898542288 scopus 로고    scopus 로고
    • Liquid biopsies: genotyping circulating tumor DNA
    • Diaz, L.A., Bardelli, A., Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32 (2014), 579–586.
    • (2014) J. Clin. Oncol. , vol.32 , pp. 579-586
    • Diaz, L.A.1    Bardelli, A.2
  • 21
    • 84968779733 scopus 로고    scopus 로고
    • Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells
    • Gorges, T.M., Penkalla, N., Schalk, T., Joosse, S.A., Riethdorf, S., Tucholski, J., Lücke, K., Wikman, H., Jackson, S., Brychta, N., et al. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clin. Cancer Res. 22 (2016), 2197–2206.
    • (2016) Clin. Cancer Res. , vol.22 , pp. 2197-2206
    • Gorges, T.M.1    Penkalla, N.2    Schalk, T.3    Joosse, S.A.4    Riethdorf, S.5    Tucholski, J.6    Lücke, K.7    Wikman, H.8    Jackson, S.9    Brychta, N.10
  • 22
    • 84973601487 scopus 로고    scopus 로고
    • Heterogeneous PSMA expression on circulating tumor cells – a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer
    • Gorges, T.M., Riethdorf, S., von Ahsen, O., Nastały, P., Röck, K., Boede, M., Peine, S., Kuske, A., Schmid, E., Kneip, C., et al. Heterogeneous PSMA expression on circulating tumor cells – a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer. Oncotarget 7 (2016), 34930–34941.
    • (2016) Oncotarget , vol.7 , pp. 34930-34941
    • Gorges, T.M.1    Riethdorf, S.2    von Ahsen, O.3    Nastały, P.4    Röck, K.5    Boede, M.6    Peine, S.7    Kuske, A.8    Schmid, E.9    Kneip, C.10
  • 27
    • 84910008796 scopus 로고    scopus 로고
    • “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease
    • Ilie, M., Hofman, V., Long-Mira, E., Selva, E., Vignaud, J.M., Padovani, B., Mouroux, J., Marquette, C.H., Hofman, P., “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One, 9, 2014, e111597.
    • (2014) PLoS One , vol.9 , pp. e111597
    • Ilie, M.1    Hofman, V.2    Long-Mira, E.3    Selva, E.4    Vignaud, J.M.5    Padovani, B.6    Mouroux, J.7    Marquette, C.H.8    Hofman, P.9
  • 28
  • 29
    • 84964671215 scopus 로고    scopus 로고
    • The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics
    • Jiang, P., Lo, Y.M., The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 32 (2016), 360–371.
    • (2016) Trends Genet. , vol.32 , pp. 360-371
    • Jiang, P.1    Lo, Y.M.2
  • 30
    • 77956357165 scopus 로고    scopus 로고
    • Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer
    • Jiang, Y., Palma, J.F., Agus, D.B., Wang, Y., Gross, M.E., Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clin. Chem. 56 (2010), 1492–1495.
    • (2010) Clin. Chem. , vol.56 , pp. 1492-1495
    • Jiang, Y.1    Palma, J.F.2    Agus, D.B.3    Wang, Y.4    Gross, M.E.5
  • 31
    • 84946572402 scopus 로고    scopus 로고
    • Tumor-educated platelets as liquid biopsy in cancer patients
    • Joosse, S.A., Pantel, K., Tumor-educated platelets as liquid biopsy in cancer patients. Cancer Cell 28 (2015), 552–554.
    • (2015) Cancer Cell , vol.28 , pp. 552-554
    • Joosse, S.A.1    Pantel, K.2
  • 45
    • 84926431987 scopus 로고    scopus 로고
    • Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
    • Morelli, M.P., Overman, M.J., Dasari, A., Kazmi, S.M., Mazard, T., Vilar, E., Morris, V.K., Lee, M.S., Herron, D., Eng, C., et al. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Ann. Oncol. 26 (2015), 731–736.
    • (2015) Ann. Oncol. , vol.26 , pp. 731-736
    • Morelli, M.P.1    Overman, M.J.2    Dasari, A.3    Kazmi, S.M.4    Mazard, T.5    Vilar, E.6    Morris, V.K.7    Lee, M.S.8    Herron, D.9    Eng, C.10
  • 49
    • 84921793301 scopus 로고    scopus 로고
    • Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer
    • Neves, R.P., Raba, K., Schmidt, O., Honisch, E., Meier-Stiegen, F., Behrens, B., Mohlendick, B., Fehm, T., Neubauer, H., Klein, C.A., et al. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer. Clin. Chem. 60 (2014), 1290–1297.
    • (2014) Clin. Chem. , vol.60 , pp. 1290-1297
    • Neves, R.P.1    Raba, K.2    Schmidt, O.3    Honisch, E.4    Meier-Stiegen, F.5    Behrens, B.6    Mohlendick, B.7    Fehm, T.8    Neubauer, H.9    Klein, C.A.10
  • 50
    • 84938414305 scopus 로고    scopus 로고
    • Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
    • Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M.H., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol. Med. 7 (2015), 1034–1047.
    • (2015) EMBO Mol. Med. , vol.7 , pp. 1034-1047
    • Olsson, E.1    Winter, C.2    George, A.3    Chen, Y.4    Howlin, J.5    Tang, M.H.6    Dahlgren, M.7    Schulz, R.8    Grabau, D.9    van Westen, D.10
  • 51
    • 84959296143 scopus 로고    scopus 로고
    • Liquid cancer biopsy: the future of cancer detection?
    • Oncology, L., Liquid cancer biopsy: the future of cancer detection?. Lancet Oncol., 17, 2016, 123.
    • (2016) Lancet Oncol. , vol.17 , pp. 123
    • Oncology, L.1
  • 52
    • 85027951858 scopus 로고    scopus 로고
    • TP53 mutations on circulating cell-free DNA
    • Pantel, K., TP53 mutations on circulating cell-free DNA. EBioMedicine 10 (2016), 15–16.
    • (2016) EBioMedicine , vol.10 , pp. 15-16
    • Pantel, K.1
  • 54
    • 84926419351 scopus 로고    scopus 로고
    • Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
    • Pestrin, M., Salvianti, F., Galardi, F., De Luca, F., Turner, N., Malorni, L., Pazzagli, M., Di Leo, A., Pinzani, P., Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol. 9 (2015), 749–757.
    • (2015) Mol. Oncol. , vol.9 , pp. 749-757
    • Pestrin, M.1    Salvianti, F.2    Galardi, F.3    De Luca, F.4    Turner, N.5    Malorni, L.6    Pazzagli, M.7    Di Leo, A.8    Pinzani, P.9
  • 60
    • 84884286445 scopus 로고    scopus 로고
    • Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
    • Schneck, H., Blassl, C., Meier-Stiegen, F., Neves, R.P., Janni, W., Fehm, T., Neubauer, H., Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients. Mol. Oncol. 7 (2013), 976–986.
    • (2013) Mol. Oncol. , vol.7 , pp. 976-986
    • Schneck, H.1    Blassl, C.2    Meier-Stiegen, F.3    Neves, R.P.4    Janni, W.5    Fehm, T.6    Neubauer, H.7
  • 62
    • 84959178370 scopus 로고    scopus 로고
    • Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients
    • Siravegna, G., Bardelli, A., Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. Mol. Oncol. 10 (2016), 475–480.
    • (2016) Mol. Oncol. , vol.10 , pp. 475-480
    • Siravegna, G.1    Bardelli, A.2
  • 68
    • 84941630950 scopus 로고    scopus 로고
    • Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
    • Tie, J., Kinde, I., Wang, Y., Wong, H.L., Roebert, J., Christie, M., Tacey, M., Wong, R., Singh, M., Karapetis, C.S., et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann. Oncol. 26 (2015), 1715–1722.
    • (2015) Ann. Oncol. , vol.26 , pp. 1715-1722
    • Tie, J.1    Kinde, I.2    Wang, Y.3    Wong, H.L.4    Roebert, J.5    Christie, M.6    Tacey, M.7    Wong, R.8    Singh, M.9    Karapetis, C.S.10
  • 69
    • 84978062740 scopus 로고    scopus 로고
    • Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
    • Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.L., Christie, M., et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl. Med., 8, 2016, 346ra392.
    • (2016) Sci. Transl. Med. , vol.8 , pp. 346ra392
    • Tie, J.1    Wang, Y.2    Tomasetti, C.3    Li, L.4    Springer, S.5    Kinde, I.6    Silliman, N.7    Tacey, M.8    Wong, H.L.9    Christie, M.10
  • 71
    • 79956298812 scopus 로고    scopus 로고
    • Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
    • Van Cutsem, E., Köhne, C.H., Láng, I., Folprecht, G., Nowacki, M.P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J. Clin. Oncol. 29 (2011), 2011–2019.
    • (2011) J. Clin. Oncol. , vol.29 , pp. 2011-2019
    • Van Cutsem, E.1    Köhne, C.H.2    Láng, I.3    Folprecht, G.4    Nowacki, M.P.5    Cascinu, S.6    Shchepotin, I.7    Maurel, J.8    Cunningham, D.9    Tejpar, S.10
  • 76
    • 84875999237 scopus 로고    scopus 로고
    • Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis
    • Yokobori, T., Iinuma, H., Shimamura, T., Imoto, S., Sugimachi, K., Ishii, H., Iwatsuki, M., Ota, D., Ohkuma, M., Iwaya, T., et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 73 (2013), 2059–2069.
    • (2013) Cancer Res. , vol.73 , pp. 2059-2069
    • Yokobori, T.1    Iinuma, H.2    Shimamura, T.3    Imoto, S.4    Sugimachi, K.5    Ishii, H.6    Iwatsuki, M.7    Ota, D.8    Ohkuma, M.9    Iwaya, T.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.